Sign up to save your podcasts
Or
Share Recently Approved Drugs: Pembrolizumab for cHL
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Recently Approved Drugs: Pembrolizumab for cHL
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
View all episodes
By American Society of Clinical Oncology (ASCO)
4.5
3131 ratings
Dr. Christina Wiedl, director of the pediatric and young adult stem cell transplant program at Virginia Commonwealth University, presents information on the recently approved drug in oncology, keytruda for relapsed and refractory classical Hodgkin lymphoma in pediatric and young adult patients.
More shows like ASCO Education
View all
JAMA Editors' Summary
131 Listeners
NEJM This Week
325 Listeners
Journal of Clinical Oncology (JCO) Podcast
38 Listeners
JAMA Clinical Reviews
496 Listeners
ASCO Daily News
58 Listeners
GeriPal - A Geriatrics and Palliative Medicine Podcast
285 Listeners
The Curbsiders Internal Medicine Podcast
3,336 Listeners
Worklife with Adam Grant
9,190 Listeners
ASCO Guidelines
43 Listeners
Throughline
16,072 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Kelly Corrigan Wonders
3,323 Listeners
Two Onc Docs
169 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
39 Listeners
Letters from an American
5,337 Listeners